THQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
THQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Tekla Healthcare Opportunities Fund does not have enough data to calculate 10-Year RORE %.
The historical data trend for Tekla Healthcare Opportunities Fund's 10-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tekla Healthcare Opportunities Fund Annual Data | |||||||||||||||||
Trend | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | Sep24 | |||||||||
10-Year RORE % | Get a 7-Day Free Trial | - | - | - | - | - |
Tekla Healthcare Opportunities Fund Semi-Annual Data | |||||||||||||||
Sep17 | Mar18 | Sep18 | Mar19 | Sep19 | Mar20 | Sep20 | Mar21 | Sep21 | Mar22 | Sep22 | Mar23 | Sep23 | Mar24 | Sep24 | |
10-Year RORE % | Get a 7-Day Free Trial | - | - | - | - | - |
For the Asset Management subindustry, Tekla Healthcare Opportunities Fund's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Asset Management industry and Financial Services sector, Tekla Healthcare Opportunities Fund's 10-Year RORE % distribution charts can be found below:
* The bar in red indicates where Tekla Healthcare Opportunities Fund's 10-Year RORE % falls into.
Tekla Healthcare Opportunities Fund's 10-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:
10-Year RORE % | = | ( Most Recent EPS (Diluted) | - | First Period EPS (Diluted) ) | / | ( Cumulative EPS (Diluted) for 10-year | - | Cumulative Dividends per Share for 10-year ) |
= | ( | - | ) | / | ( | - | ) | |
= | / | |||||||
= | N/A % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 10-year before.
Tekla Healthcare Opportunities Fund (NYSE:THQ) 10-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Thank you for viewing the detailed overview of Tekla Healthcare Opportunities Fund's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Rose Dimartino | director | C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103 |
Kathleen Goetz | director | 1310 OAK VALLEY CIRCLE, POLK CITY IA 50226 |
Bill Maher | director | 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101 |
Aberdeen Standard Investments Inc. | other: Adviser | 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103 |
Jaclyn Marie Matsick | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Marika Tooze | other: Director of Adviser | C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Todd Reit | director | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
James Joseph O'connor | other: Director of Adviser | C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103 |
Lucia Sitar | officer: VP and Chief Legal Officer | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Christian Pittard | officer: President | ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH |
Jennifer A Nichols | other: Director of Adviser | 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103 |
Stephen Bird | director | 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022 |
Joseph Andolina | officer: Chief Compliance Officer & VP | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Alan R Goodson | officer: Vice President | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
Sharon Ferrari | officer: Treasurer and CFO | 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103 |
From GuruFocus
By Business Wire • 08-10-2023
By Business Wire Business Wire • 05-31-2023
By Business Wire Business Wire • 02-28-2023
By Business Wire Business Wire • 06-09-2023
By GuruFocus Research • 01-23-2024
By Business Wire • 08-31-2023
By Business Wire Business Wire • 08-31-2022
By Business Wire Business Wire • 07-29-2022
By Business Wire Business Wire • 08-10-2022
By Business Wire Business Wire • 12-30-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.